Santa Cruz Biotechnology provides a broad selection of CKR-2B monoclonal antibodies for research focused on understanding CKR-2B protein function. CKR-2B monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CKR-2B, also known as chemokine receptor 2B, plays a crucial role in mediating immune responses by binding to specific chemokines. The receptor regulates cell migration and activation, making it significant in both normal physiological processes and pathological conditions, such as inflammation and cancer. Understanding CKR-2B function is essential for developing targeted therapies and advancing knowledge of immune system dynamics. Researchers can utilize CKR-2B monoclonal antibodies to investigate receptor expression patterns in various cell types. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of CKR-2B localization and expression. Exploring CKR-2B's role in cellular signaling pathways can reveal new insights into immune regulation mechanisms. Santa Cruz Biotechnology monoclonal antibodies for CKR-2B support researchers worldwide in advancing scientific understanding of immune system function and disease mechanisms.